THE STATE OF NUTRITIONAL STATUS AND ITS IMPACT ON THE LEVEL OF COMORBIDITY IN PATIENTS ON HEMODIALYSIS

The aim of the study was to investigate the nutritive status and identify risk factors for cardiovascular disease in patients on hemodialysis.

Material and methods. 144 patients on program hemodialysis were examined. All patients underwent general clinical and laboratory examination, lipid profile was examined, body mass index was calculated, waist and hip circumference was measured, ratio of waist circumference to the circumference of hip was determined, abdominal integral multi-frequency bioimpedansometry and multispiral computed tomography were performed.

Results. Gender features of distribution of abdominal adipose tissue and dyslipidemia in patients on program hemodialysis were revealed. Women have a predominant accumulation of visceral adipose tissue, while men are characterized by a proportional distribution of subcutaneous and visceral adipose tissue in the abdominal area. Women compared to men have higher rates of atherogenic lipoprotein fractions, which level is closely related to the volume of visceral adipose tissue. Among the comorbidities in the examined patients, diseases of the cardiovascular system predominate. The regression analysis revealed that the most significant risk factor for the development of coronary artery disease is an increase in lowdensity lipoproteins, for chronic heart failure – an increase in waist circumference.

Conclusions. The data obtained indicate the need to monitor the nutritional status of patients on hemodialysis to identify and correct risk factors for cardiovascular disease.

1. Bikbov B.T., Tomilina N.A. Renal replacement therapy for ESRD patients in Russian Federation, 1998–2011. Report of Russian RRT Registry. Part 1. Nefrologiya i dializ = Nephrology and Dialysis. 2014; (1): 11–127.

2. Bikbov B.T., Tomilina N.A. The contingent and treatment quality indicators in patients on replacement therapy of end stage renal disease in the Russian Federation in 1998-2013 years. Report of the Register of Renal Replacement Therapy of the Russian Dialysis Society. Part II. Nefrologiya i dializ = Nephrology and Dialysis. 2016; 18 (2): 98–164.

3. Milovanov Yu.S., Milovanova N.I. Disorders of nutritional status in renal failure. Moscow: GEOTARMedia, 2016.

4. Rtishcheva O.B., Kaleev O.F. Age-sex characteristics of lipid metabolism in patients receiving treatment with program hemodialysis. Klinicheskaya nefrologiya = Clinical Nephrology. 2010; (4): 55–58.

5. Al-Daghri N.M., Al-Attas O.S., Alokail M.S., Alkharfy KM., Charalampidis P., Livadas S., Kollias A., Sabico S.L., Chrousos G.P. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur. J. Clin. Invest. 2013; 43 (2): 183–189. doi: 10.1111/eci.12030

6. Amato M.C., Giordano C., Galia M., Criscimanna A., Vitabile S., Midiri M., Galluzzo A., AlkaMeSy Study Group. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33 (4): 920–922. doi: 10.2337/dc09-1825

7. Badve S.V., Paul S.K., Klein K., Clayton P.A., Hawley C.M., Brown F.G., Boudville N., Polkinghorne K.R., McDonald S.P., Johnson D.W. The association between body mass index and mortality in incident dialysis patients. PLoS One. 2014; 16; 9 (12): e114897. doi: 10.1371/journal.pone.0114897

8. Bevc S., Potočnic A., Hojs R. Lipids, waist circumference and body mass index in haemodialysis patients. J. Int. Med. Res. 2011; 39 (3): 1063–1074. doi: 10.1177/147323001103900341

9. Burmeister J.E., Mosmann C.B., Costa V.B., Saraiva R.T., Grandi R.R., Bastos J.P., Goncalves L.F., Rosito G.A. Prevalence of cardiovascular risk factors in hemodialysis patients – The CORDIAL study. Arq. Bras. Cardiol. 2014; 102 (5): 473–480. doi: 0.5935/abc.20140048

10. Chazot C., Deleaval P., Bernollin A.L., VoVan C., Lorriaux C., Hurot J.M., Mayor B., Jean G. Target weight gain during the first year of hemodialysis therapy is associated with patient survival. Nephron. Clin. Pract. 2014; 126 (3): 128–134. doi: 10.1159/000362211

11. Chen H.Y., Lin C.C., Chiu Y.L., Hsu S.P., Pai M.F., Yang J.Y., Peng Y.S. Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One. 2012; 7 (7): e38415. doi: 10.1371/journal.pone.0038415

12. Cordeiro A.C., Qureshi A.R., Lindholm B., Amparo F.C., Tito-Paladino-Filho A., Perini M., Lourenco F.S., Pinto I.M., Amodeo C., Carrero J.J. Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol. Dial. Transplant. 2013; 28, Suppl. 4: iv152–iv159. doi: 10.1093/ndt/gft250

13. Cordeiro A.C., Qureshi A.R., Stenvinkel P., Heimburger O., Axelsson J., Barany P., Lindholm B., Carrero J.J. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol. Dial. Transplant. 2010; 25 (2): 562–568. doi: 10.1093/ndt/gfp492

14. DeNino W.F., Tchernof A., Dionne I.J., Toth M.J., Ades P.A., Sites C.K., Poehlman E.T. Contribution of abdominal adiposity to age-related difference in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001; 24 (5): 925–932. doi: 10.2337/diacare.24.5.925

15. Ferreira J.P., Couchoud C., Gregson J., Tiple A., Glowacki F., London G., Agarwal R., Rossignol P. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study. Nephrol. Dial. Transplant. 2019; 34 (7): 1216–1222. doi: 10.1093/ndt/gfy378

16. Heerspink H.J., Ninomiya T., Zoungas S., de Zeeuw D., Grobbee D.E., Jardine M.J., Gallagher M., Roberts M.A., Cass A., Neal B., Perkovic V. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009; 373 (9668): 1009–1015. doi: 10.1016/S0140-6736(09)60212-9

17. Honda H., Qureshi A.R., Axelsson J., Heimburger O., Suliman M.E., Barany P., Stenvinkel P., Lindholm B. Obese sarcopenia in patients with endstage renal disease in associated with inflammation and increased mortality. Am. J. Clin. Nutr. 2007; 86 (3): 633–638. doi: 10.1093/ajcn/86.3.633

18. Ishimura E., Okuno S., Tsuboniwa N., Shoji S., Yamakawa T., Nishizawa Y., Inaba M. Relationship between fat mass and serum high-sensitivity C-reactive protein levels in prevalent hemodialysis patients. Nephron Clin. Pract. 2011; 119 (4): 283–288. doi: 10.1159/000328931

19. Kalantar-Zadeh K., Rhee C.M., Chou J., Ahmadi S.F., Park J., Chen J.L., Amin A.N. The obesity paradox in kidney disease: how to reconcile it with obesity management. Kidney Int. Rep. 2017; 2 (2): 271–281. doi: 10.1016/j.ekir.2017.01.009

20. Kato A., Ishida J., Endo Y., Takita T., Furuhashi M., Maruyama Y., Odamaki M. Association of abdominal visceral adiposity and thigh sacropenia with changes of arteriosclerosis in haemodialysis patients. Nephrol. Dial. Transplant. 2011; 26 (6): 1927–1976. doi: 10.1093/ndt/gfq652

21. Moriyama Y., Eriguchi R., Sato Y., Nakaya Y. Chronic hemodialysis patients with visceral obesity have a higher risk for cardiovascular events. Asia Pac. J. Clin. Nutr. 2011; 20 (1): 109–117.

22. Neeland I.J., Turer A.T., Ayers C.R., PowellWiley T.M., Vega G.L., Farzaneh-Far R., Grundy S.M., Khera A., McGuire D.K., de Lemos J.A. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012; 308 (11): 1150–1159. doi: 10.1001/2012.jama.1113

23. Noori N., Kovesdy C.P., Dukkipati R., Kim Y., Duong U., Bross R., OreopoulosA., LunaA., Benner D., Kopple J.D., Kalantar-Zadeh K. Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis. Am. J. Clin. Nutr. 2010; 92 (5): 1060–1070. doi: 10.3945/ajcn.2010.29188.

24. Odamaki M., Furuya R., Ohkawa S. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol. Dial. Transplant. 1999; 14 (10): 2427–2432.

25. Ohkawa S., Odamaki M., Ikegaya N., Hibi I., Miyaji K., Kumagai H. Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients. Nephrol. Dial. Transplant. 2005; 20: 945–951. doi: 10.1093/ndt/gfh643

26. Okamoto T., Hatakeyama S., Kodama H., Horiguchi H., Kubota Y., Kido K., Momota M., Hosogoe S., Tanaka Y., Takashima T., Saitoh F., Suzuki T., Ohyama C. The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis. BMC Nephrol. 2018; 19 (1): 71. doi: 10.1186/s12882-018-0872-y

27. Panzetta G., Abaterusso C. Obesity in dialysis and reverse epidemiology: true or false? G. Ital. Nefrol. 2010; 27 (6): 629–638.

28. Portoles J., Lopez-Gomez J.M., Aljama P. Riesgo cardiovascular en hemodialisis enEspana: prevalencia, pautas de actuacion yobjetivos (estudio MAR). Nefrologia. 2005; 25 (3): 297–306.

29. Portoles J., Lopez-Gomez J.M., Aljama P. Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study). Nefrologia = Nephrology. 2005; 25 (3): 297–306. [In Spain].

30. Postorino M., Marino C., Tripepi G., Zoccali C., CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J. Am. Coll. Cardiol. 2009: 53 (15): 1265–1272. doi: 10.1016/j.jacc.2008.12.040

31. Ryo M., Kishida K., Nakamura T., Yoshizumi T., Funahashi T., Shimomura I. Clinical significance of visceral adiposity assessed by computed tomography: A Japanese perspective. World J. Radiol. 2014; 6 (7): 409–416. doi: 10.4329/wjr.v6.i7.409

32. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., McCullough P.A., Kasiske B.L., Kelepouris E., Klag M.J., Parfrey P., Pfeffer M., Raij L., Spinosa D.J., Wilson P.W. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108 (17): 2154–2169. doi: 10.1161/01.CIR.0000095676.90936.80

33. Yurugi T., Morimoto S., Okamoto T., Amari Y., Kasuno Y., Fukui M., Nakajima F., Nishikawa M., Iwasaka T. Accumulation of visceral fat in maintenance hemodialysis patients. Clin. Exp. Nephrol. 2012; 16 (1): 156–163. doi: 10.1007/s10157-011-0544-8